Volumetric Analysis of Subthalamic Nucleus and Red Nucleus in Patients of Advanced Parkinson's Disease Using SWI Sequences

Overview

Journal Surg Neurol Int

Specialty Neurology

Date 2021 Sep 13

PMID 34513144

Citations 4

Authors

Swapnil Kolpakwar

Abhishek J Arora

S Pavan

Rukmini M Kandadai

Rajesh Alugolu

M Vijaya Saradhi

Rupam Borgohain

Affiliations

Soon will be listed here.

Abstract

Background: Parkinson's disease is associated with significant changes in morphometry of subthalamic nucleus (STN); however, not much is known as the disease progresses. The aim of present study was to investigate the volume of STN and Red nucleus (RN) on 3T-magnetic resonance imaging (MRI) and its possible correlation with disease progression in advanced Parkinson's disease patients.

Methods: Patients of advanced Parkinson's disease were prospectively followed for clinical details, motor severity scores, and radiological evaluation. Volumes of the STN and RN were measured on susceptibility weighted imaging, coronal sections in 3T MRI and were correlated with demographic and clinical features.

Results: A total of 52 patients were included in our study. There were 42 (80.77%) males and 10 (19.23%) females. Mean age of onset of Parkinson's disease was 49.48 + 10.90 years. Average duration of disease in the present cohort was 7.65 + 4.31 years. Average STN and RN volume were 103.46 + 21.17 mm and 321.73 + 67.66 mm. Age of onset, disease duration and Unified Parkinson's Disease Rating Scale Part III scores were not found to be associated with changes in STN Volumes. Weak positive trend was noted between RN volume and disease duration (Pearson cor. 0.204, = 0.14). Patients in early-onset Parkinson's disease group had significantly more volume of RN than patients in late-onset Parkinson's disease group ( = 0.014).

Conclusion: Disease duration and early age of onset in Parkinson's disease can be associated with increased RN volume. Volume of STN shows relatively no change even with disease progression.

Citing Articles

Direct comparison between F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy.

Satoh R, Ali F, Botha H, Lowe V, Josephs K, Whitwell J Neuroimage. 2024; 286:120509.

PMID: 38184157 PMC: 10868646. DOI: 10.1016/j.neuroimage.2024.120509.

Diagnostic value of combined magnetic resonance imaging techniques in the evaluation of Parkinson disease.

Cao Q, Han X, Tang D, Qian H, Yan K, Shi X Quant Imaging Med Surg. 2023; 13(10):6503-6516.

PMID: 37869346 PMC: 10585559. DOI: 10.21037/qims-23-87.

Magnetic susceptibility changes in the brainstem reflect REM sleep without atonia severity in isolated REM sleep behavior disorder.

Nepozitek J, Varga Z, Dostalova S, Perinova P, Keller J, Robinson S NPJ Parkinsons Dis. 2023; 9(1):112.

PMID: 37452075 PMC: 10349141. DOI: 10.1038/s41531-023-00557-2.

Application value of multiparametric MRI for evaluating iron deposition in the substantia nigra in Parkinson's disease.

Cao Q, Huang J, Tang D, Qian H, Yan K, Shi X Front Neurol. 2023; 13:1096966.

PMID: 36686531 PMC: 9846143. DOI: 10.3389/fneur.2022.1096966.

References

Gasparotti R, Pinelli L, Liserre R . New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essay. Insights Imaging. 2012; 2(3):335-347. PMC: 3259351. DOI: 10.1007/s13244-011-0086-3. View

Remple M, Bradenham C, Chris Kao C, Charles P, Neimat J, Konrad P . Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression. Mov Disord. 2011; 26(9):1657-62. PMC: 3151310. DOI: 10.1002/mds.23708. View

Shen W, Wang H, Lin Z, Shen H, Chen X, Fu Y . Stereotactic localization and visualization of the subthalamic nucleus. Chin Med J (Engl). 2010; 122(20):2438-43. View

OGorman R, Shmueli K, Ashkan K, Samuel M, Lythgoe D, Shahidiani A . Optimal MRI methods for direct stereotactic targeting of the subthalamic nucleus and globus pallidus. Eur Radiol. 2010; 21(1):130-6. DOI: 10.1007/s00330-010-1885-5. View

Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A . Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain. 1998; 121 ( Pt 3):451-7. DOI: 10.1093/brain/121.3.451. View

Hardman C, Halliday G, McRitchie D, Morris J . The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol. 1997; 56(2):132-42. DOI: 10.1097/00005072-199702000-00003. View

Plaha P, Ben-Shlomo Y, Patel N, Gill S . Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain. 2006; 129(Pt 7):1732-47. DOI: 10.1093/brain/awl127. View

McIntyre C, Mori S, Sherman D, Thakor N, Vitek J . Electric field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus. Clin Neurophysiol. 2004; 115(3):589-95. DOI: 10.1016/j.clinph.2003.10.033. View

Vertinsky A, Coenen V, Lang D, Kolind S, Honey C, Li D . Localization of the subthalamic nucleus: optimization with susceptibility-weighted phase MR imaging. AJNR Am J Neuroradiol. 2009; 30(9):1717-24. PMC: 7051506. DOI: 10.3174/ajnr.A1669. View

10.

Habas C, Cabanis E . Cortical projections to the human red nucleus: a diffusion tensor tractography study with a 1.5-T MRI machine. Neuroradiology. 2006; 48(10):755-62. DOI: 10.1007/s00234-006-0117-9. View

11.

Massey L, Miranda M, Zrinzo L, Al-Helli O, Parkes H, Thornton J . High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage. 2011; 59(3):2035-44. DOI: 10.1016/j.neuroimage.2011.10.016. View

12.

Cheng C, Huang H, Lin H, Chiou S . 1.5T versus 3T MRI for targeting subthalamic nucleus for deep brain stimulation. Br J Neurosurg. 2013; 28(4):467-70. DOI: 10.3109/02688697.2013.854312. View

13.

Bergman H, Wichmann T, Karmon B, DeLong M . The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol. 1994; 72(2):507-20. DOI: 10.1152/jn.1994.72.2.507. View

14.

Lewis M, Du G, Kidacki M, Patel N, Shaffer M, Mailman R . Higher iron in the red nucleus marks Parkinson's dyskinesia. Neurobiol Aging. 2012; 34(5):1497-503. PMC: 3570638. DOI: 10.1016/j.neurobiolaging.2012.10.025. View

15.

Abosch A, Yacoub E, Ugurbil K, Harel N . An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla. Neurosurgery. 2010; 67(6):1745-56. PMC: 3124849. DOI: 10.1227/NEU.0b013e3181f74105. View

16.

Pringsheim T, Jette N, Frolkis A, Steeves T . The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014; 29(13):1583-90. DOI: 10.1002/mds.25945. View

17.

Levesque J, Parent A . GABAergic interneurons in human subthalamic nucleus. Mov Disord. 2005; 20(5):574-84. DOI: 10.1002/mds.20374. View

18.

Welter M, Schupbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard J . Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology. 2014; 82(15):1352-61. PMC: 4001189. DOI: 10.1212/WNL.0000000000000315. View

19.

den Dunnen W, Staal M . Anatomical alterations of the subthalamic nucleus in relation to age: a postmortem study. Mov Disord. 2005; 20(7):893-8. DOI: 10.1002/mds.20417. View

20.

Colpan M, Slavin K . Subthalamic and red nucleus volumes in patients with Parkinson's disease: do they change with disease progression?. Parkinsonism Relat Disord. 2010; 16(6):398-403. DOI: 10.1016/j.parkreldis.2010.03.008. View